Pilot Observational Study of an Integrative Cure Stay Program

Sponsor
University Hospital, Basel, Switzerland
Study ID
NCT07398079
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Integrative Cure Stay — BEHAVIORAL
    Participants attend a 7-day integrative oncology retreat including individualized consultations, complementary therapies, and group-based mind-body interventions
  • Matched Control Group — OTHER
    Participants receive usual oncology follow-up without attending the retreat

Study Details

This pilot observational study evaluates the feasibility and acceptability of conducting a prospective study alongside the individualized integrative oncology cure stay program "Via Shalva" for breast and gynecological cancer survivors. The study further explores preliminary changes in patient-reported outcomes, physiological measures, and biological markers before and after the retreat and compared with a matched control group.

Key Dates

First listed
Feb 9, 2026
Start date
Oct 6, 2025
Status verified
Feb 2026
Primary completion
Dec 31, 2026
Completion
Jun 30, 2027

Study Design

Enrollment
30 participants (estimated)

Arms

  • Arm: Integrative Cure Stay Group
    Participants attend a 7-day integrative oncology retreat including individualized consultations, complementary therapies, and group-based mind-body interventions.
  • Arm: Matched Control Group
    Participants receive usual oncology follow-up without attending the retreat.

Primary Outcome Measure

Feasibility of Study Conduct (Composite Outcome) [ Time Frame: Baseline to 6 months ]

Central Contacts

Find similar trials

Nationwide
Breast cancer trialsOncology trialsBreast oncology trialsWomen's health trials

Related Studies